Skip to content
Search

Latest Stories

Patients experience lower mortality rates when treated by female doctors, study reveals

Patients experience lower mortality rates when treated by female doctors, study reveals

Women are more likely to benefit from receiving treatment from female doctors than men

If you believe you'll feel better under the care of a female doctor, you may not be wrong. Researcher have found a correlation between the gender of physicians and clinical outcomes for patients.


Hospital patients have lower mortality and readmission rates when treated by female physicians, according to a study published recently in the journal Annals of Internal Medicine.

Moreover, the benefit of receiving care from female physicians was found to be larger for female patients than for male patients.

Female patients showed a mortality rate of 8.15 per cent when treated by a female doctor, compared to 8.38 per cent under the care of a male physician.

Among men, 10.15 per cent experienced mortality within 30 days of discharge under the care of a female doctor, compared to 10.23 percent with a male physician.

It is a small but “significant” difference, noted the scientists from the University of California, Los Angeles (UCLA) who suggested that the difference could be due to male doctors underestimating the severity of their female patients’ illnesses.

They also proposed that the effect could be due to female doctors communicating with their female patients better, and women finding it more comfortable engaging in detailed and sensitive conversations with doctors of the same gender, potentially resulting in better diagnoses and treatment.

Dr Yusuke Tsugawa, the senior author of the study and an associate professor at the David Geffen School of Medicine at UCLA, noted that their research indicated disparities in medical practice between female and male physicians, with a significant impact on patients' health outcomes.

For the study, the researchers used data of Medicare fee-for-service beneficiaries hospitalized with medical conditions between 2016 and 2019 in the United States.

Of 458,100 female and 319,800 male patients included in the study, approximately 31 percent of them were treated by female physicians.

The study found that female patients had a lower likelihood of being readmitted within 30 days if they were under the care of a female doctor. Specifically, 15.23 percent of women with a female physician were readmitted, compared with 16.71 percent of women with a male physician.

Dr Tsugawa emphasised the importance of conducting additional research into the underlying mechanisms linking physician gender with patient outcomes, as well as understanding why the benefits differed between female and male patients.

This exploration has “the potential to improve patient outcomes across the board,” he said.

Acknowledging that female physicians deliver high-quality care and that increasing their representation benefits patients, the researchers recommended addressing pay disparities within the profession.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less